Citizens analyst Silvan Tuerkcan reiterated a Market Outperform rating and $8.00 price target on Cellectis (NASDAQ: CLLS).The analyst commented, "Cellectis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE